1. Deng, Peng, Wang, Zining, Chen, Jinghong, Xia, Xiaojun, Tan, Jing. 2022. RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer. In The Journal of clinical investigation, 132, . doi:10.1172/JCI159628. https://pubmed.ncbi.nlm.nih.gov/36201246/
2. Cui, Rongrong, Chen, Pu, Wang, Yuanyuan, Hou, Peng, Qu, Yiping. 2022. Cohesin RAD21 Gene Promoter Methylation Correlated with Better Prognosis in Breast Cancer Patients. In Cytogenetic and genome research, 162, 109-118. doi:10.1159/000524735. https://pubmed.ncbi.nlm.nih.gov/35654004/
3. Manola, Kalliopi N, Zachaki, Sophia, Kakosaiou, Katerina, Kalomoiraki, Marina, Rampias, Theodoros. 2024. Cohesin RAD21 Gene Promoter Methylation in Patients with Acute Myeloid Leukemia. In Life (Basel, Switzerland), 14, . doi:10.3390/life14101311. https://pubmed.ncbi.nlm.nih.gov/39459611/
4. Su, Xiaofeng A, Stopsack, Konrad H, Schmidt, Daniel R, Amon, Angelika, Mucci, Lorelei A. 2024. RAD21 promotes oncogenesis and lethal progression of prostate cancer. In Proceedings of the National Academy of Sciences of the United States of America, 121, e2405543121. doi:10.1073/pnas.2405543121. https://pubmed.ncbi.nlm.nih.gov/39190349/